Skip to main navigation Skip to search Skip to main content

A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis

  • Anwar R. Padhani*
  • , Ivo G. Schoots
  • , Baris Turkbey
  • , Gianluca Giannarini
  • , Jelle O. Barentsz
  • *Corresponding author for this work
  • East and North Hertfordshire NHS Trust
  • National Cancer Institute (Bethesda, Md)
  • S. Maria Della Misericordia Hospital
  • Radboud University Medical Center

Research output: Contribution to journalEditorialAcademicpeer-review

28 Citations (Scopus)

Abstract

• Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis. • Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working. • Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.

Original languageEnglish
Pages (from-to)4386-4389
Number of pages4
JournalEuropean Radiology
Volume31
Issue number6
DOIs
Publication statusPublished - Jun 2021

Bibliographical note

Publisher Copyright: © 2020, European Society of Radiology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis'. Together they form a unique fingerprint.

Cite this